Press Releases

Petra Pharma Strengthens Management Team With Recent Leadership Appointments

Albert S. Yu, M.D., appointed Chief Medical Officer and Clive Bertram appointed Head of Corporate Development.

Go To Release

Petra Pharma announces licensing agreement with Takeda Pharmaceutical Company

Deal expands Petra’s portfolio, accelerating progress to Phase 2 clinical stage company.

Go To Release

Petra Pharma Presents Preclinical PIP4K2 Inhibitor Data as a Potential Treatment for Hematologic Malignancies at the 2018 American Society of Hematology Annual Meeting

Go To Release

Evotec Forms Collaboration with Petra Pharma on Indigo Platform

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today a strategic collaboration with Petra Pharma Corporation ("Petra").

Go To Release

Petra Pharma and Schrödinger Announce Research Collaboration

Petra Pharma and Schrödinger, Inc. announced a research collaboration to develop novel therapeutics for the treatment of cancer and metabolic diseases.

Go To Release

Petra Pharma Appoints Executive and Scientific Leadership Teams

Petra Pharma Corporation announced today it appointed an executive leadership team and named a Scientific Advisory Board.

Go To Release

Accelerator Corporation Launches First Startup in New York City Portfolio

Accelerator Corporation announced the financing of Petra Pharma Corporation to develop small molecule inhibitors for the treatment of cancer and metabolic diseases.

Download PDF

© Petra Pharma Corporation